RHODES PHARMACEUTICALS LP Discontinued
FDA Approved Drugs

RHODES PHARMACEUTICALS LP Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 26
  • Latest Approval Date Nov 04, 2025
  • Data Source FDA
  • First Approval Date Feb 10, 1988
All
87
View
Unclassified
3
View
Discontinued
26
View
RX
58
View
Company Overview

Company

RHODES PHARMACEUTICALS LP Discontinued

Country

U.S.A

Website

Visit Website

Email

Social Profiles

Company Snapshot

RHODES PHARMACEUTICALS LP Discontinued

498 Washington StreetCoventry, RI 02816

U.S.A

www.rhodespharma.com:443/ View on Map
FDA Approved Drug Records ( 26 records )
1988
10 Feb
Discontinued Application: 89673

Drug Name

ACETAMINOPHEN AND CODEINE PHOSPHATE

Product Number

1

Dosage Form

-

Strength

300MG;60MG

Approval Date

1988-02-10

89673 / 1

Active Ingredient

ACETAMINOPHEN; CODEINE PHOSPHATE

Application Number

89673

Product Number

1

Dosage Form

-

Strength

300MG;60MG

Approval Date

1988-02-10

Regulatory Status

Discontinued

1988
10 Feb
Discontinued Application: 89673

Drug Name

ACETAMINOPHEN AND CODEINE PHOSPHATE

Product Number

2

Dosage Form

-

Strength

300MG;15MG

Approval Date

1988-02-10

89673 / 2

Active Ingredient

ACETAMINOPHEN; CODEINE PHOSPHATE

Application Number

89673

Product Number

2

Dosage Form

-

Strength

300MG;15MG

Approval Date

1988-02-10

Regulatory Status

Discontinued

1988
10 Feb
Discontinued Application: 89673

Drug Name

ACETAMINOPHEN AND CODEINE PHOSPHATE

Product Number

3

Dosage Form

-

Strength

300MG;30MG

Approval Date

1988-02-10

89673 / 3

Active Ingredient

ACETAMINOPHEN; CODEINE PHOSPHATE

Application Number

89673

Product Number

3

Dosage Form

-

Strength

300MG;30MG

Approval Date

1988-02-10

Regulatory Status

Discontinued

2021
07 Sep
Discontinued Application: 213852

Drug Name

AMPHETAMINE SULFATE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2021-09-07

213852 / 1

Active Ingredient

AMPHETAMINE SULFATE

Application Number

213852

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2021-09-07

Regulatory Status

Discontinued

2021
07 Sep
Discontinued Application: 213852

Drug Name

AMPHETAMINE SULFATE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2021-09-07

213852 / 2

Active Ingredient

AMPHETAMINE SULFATE

Application Number

213852

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2021-09-07

Regulatory Status

Discontinued

2020
05 Nov
Discontinued Application: 202955

Drug Name

BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE

Product Number

1

Dosage Form

-

Strength

2MG/5ML;10MG/5ML;30MG/5ML

Approval Date

2020-11-05

202955 / 1

Active Ingredient

BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Application Number

202955

Product Number

1

Dosage Form

-

Strength

2MG/5ML;10MG/5ML;30MG/5ML

Approval Date

2020-11-05

Regulatory Status

Discontinued

2017
20 Nov
Discontinued Application: 208756

Drug Name

DEXMETHYLPHENIDATE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2017-11-20

208756 / 1

Active Ingredient

DEXMETHYLPHENIDATE HYDROCHLORIDE

Application Number

208756

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2017-11-20

Regulatory Status

Discontinued

2017
20 Nov
Discontinued Application: 208756

Drug Name

DEXMETHYLPHENIDATE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2017-11-20

208756 / 2

Active Ingredient

DEXMETHYLPHENIDATE HYDROCHLORIDE

Application Number

208756

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2017-11-20

Regulatory Status

Discontinued

2017
20 Nov
Discontinued Application: 208756

Drug Name

DEXMETHYLPHENIDATE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2017-11-20

208756 / 3

Active Ingredient

DEXMETHYLPHENIDATE HYDROCHLORIDE

Application Number

208756

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2017-11-20

Regulatory Status

Discontinued

2018
30 Mar
Discontinued Application: 207808

Drug Name

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Product Number

1

Dosage Form

-

Strength

300MG;5MG

Approval Date

2018-03-30

207808 / 1

Active Ingredient

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Application Number

207808

Product Number

1

Dosage Form

-

Strength

300MG;5MG

Approval Date

2018-03-30

Regulatory Status

Discontinued

2018
30 Mar
Discontinued Application: 207808

Drug Name

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Product Number

2

Dosage Form

-

Strength

300MG;7.5MG

Approval Date

2018-03-30

207808 / 2

Active Ingredient

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Application Number

207808

Product Number

2

Dosage Form

-

Strength

300MG;7.5MG

Approval Date

2018-03-30

Regulatory Status

Discontinued

2018
30 Mar
Discontinued Application: 207808

Drug Name

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Product Number

3

Dosage Form

-

Strength

300MG;10MG

Approval Date

2018-03-30

207808 / 3

Active Ingredient

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Application Number

207808

Product Number

3

Dosage Form

-

Strength

300MG;10MG

Approval Date

2018-03-30

Regulatory Status

Discontinued

2025
04 Nov
Discontinued Application: 216143

Drug Name

MARAVIROC

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2025-11-04

216143 / 1

Active Ingredient

MARAVIROC

Application Number

216143

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2025-11-04

Regulatory Status

Discontinued

2025
04 Nov
Discontinued Application: 216143

Drug Name

MARAVIROC

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2025-11-04

216143 / 2

Active Ingredient

MARAVIROC

Application Number

216143

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2025-11-04

Regulatory Status

Discontinued

2022
31 May
Discontinued Application: 214111

Drug Name

METHYLPHENIDATE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

18MG

Approval Date

2022-05-31

214111 / 1

Active Ingredient

METHYLPHENIDATE HYDROCHLORIDE

Application Number

214111

Product Number

1

Dosage Form

-

Strength

18MG

Approval Date

2022-05-31

Regulatory Status

Discontinued

2022
31 May
Discontinued Application: 214111

Drug Name

METHYLPHENIDATE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

27MG

Approval Date

2022-05-31

214111 / 2

Active Ingredient

METHYLPHENIDATE HYDROCHLORIDE

Application Number

214111

Product Number

2

Dosage Form

-

Strength

27MG

Approval Date

2022-05-31

Regulatory Status

Discontinued

2022
31 May
Discontinued Application: 214111

Drug Name

METHYLPHENIDATE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

36MG

Approval Date

2022-05-31

214111 / 3

Active Ingredient

METHYLPHENIDATE HYDROCHLORIDE

Application Number

214111

Product Number

3

Dosage Form

-

Strength

36MG

Approval Date

2022-05-31

Regulatory Status

Discontinued

2022
31 May
Discontinued Application: 214111

Drug Name

METHYLPHENIDATE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

54MG

Approval Date

2022-05-31

214111 / 4

Active Ingredient

METHYLPHENIDATE HYDROCHLORIDE

Application Number

214111

Product Number

4

Dosage Form

-

Strength

54MG

Approval Date

2022-05-31

Regulatory Status

Discontinued

2017
22 Jun
Discontinued Application: 206308

Drug Name

MORPHINE SULFATE

Product Number

1

Dosage Form

-

Strength

10MG/5ML

Approval Date

2017-06-22

206308 / 1

Active Ingredient

MORPHINE SULFATE

Application Number

206308

Product Number

1

Dosage Form

-

Strength

10MG/5ML

Approval Date

2017-06-22

Regulatory Status

Discontinued

2017
22 Jun
Discontinued Application: 206308

Drug Name

MORPHINE SULFATE

Product Number

2

Dosage Form

-

Strength

100MG/5ML

Approval Date

2017-06-22

206308 / 2

Active Ingredient

MORPHINE SULFATE

Application Number

206308

Product Number

2

Dosage Form

-

Strength

100MG/5ML

Approval Date

2017-06-22

Regulatory Status

Discontinued

2016
12 Jul
Discontinued Application: 206420

Drug Name

MORPHINE SULFATE

Product Number

1

Dosage Form

-

Strength

20MG/5ML

Approval Date

2016-07-12

206420 / 1

Active Ingredient

MORPHINE SULFATE

Application Number

206420

Product Number

1

Dosage Form

-

Strength

20MG/5ML

Approval Date

2016-07-12

Regulatory Status

Discontinued

2020
29 Apr
Discontinued Application: 205853

Drug Name

OXYCODONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG/5ML

Approval Date

2020-04-29

205853 / 1

Active Ingredient

OXYCODONE HYDROCHLORIDE

Application Number

205853

Product Number

1

Dosage Form

-

Strength

100MG/5ML

Approval Date

2020-04-29

Regulatory Status

Discontinued

1996
15 Apr
Discontinued Application: 40086

Drug Name

THEOPHYLLINE

Product Number

1

Dosage Form

-

Strength

600MG

Approval Date

1996-04-15

40086 / 1

Active Ingredient

THEOPHYLLINE

Application Number

40086

Product Number

1

Dosage Form

-

Strength

600MG

Approval Date

1996-04-15

Regulatory Status

Discontinued

2023
11 May
Discontinued Application: 214113

Drug Name

THEOPHYLLINE

Product Number

1

Dosage Form

-

Strength

300MG

Approval Date

2023-05-11

214113 / 1

Active Ingredient

THEOPHYLLINE

Application Number

214113

Product Number

1

Dosage Form

-

Strength

300MG

Approval Date

2023-05-11

Regulatory Status

Discontinued

2025
21 May
Discontinued Application: 213268

Drug Name

VARENICLINE TARTRATE

Product Number

1

Dosage Form

-

Strength

EQ 0.5MG BASE

Approval Date

2025-05-21

213268 / 1

Active Ingredient

VARENICLINE TARTRATE

Application Number

213268

Product Number

1

Dosage Form

-

Strength

EQ 0.5MG BASE

Approval Date

2025-05-21

Regulatory Status

Discontinued

2025
21 May
Discontinued Application: 213268

Drug Name

VARENICLINE TARTRATE

Product Number

2

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2025-05-21

213268 / 2

Active Ingredient

VARENICLINE TARTRATE

Application Number

213268

Product Number

2

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2025-05-21

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    87 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
26 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ACETAMINOPHEN AND CODEINE PHOSPHATE

Application Number

89673

Product Number

1

Active Ingredient

ACETAMINOPHEN; CODEINE PHOSPHATE

Dosage Form

-

Strength

300MG;60MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit